Clinical Trials Browser

Active not recruiting × entinostat × Genitourinary × Clear all

Carcinoma, Renal Cell

NCT04708470 2025-12-31

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT03978624 2025-10-15

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Phase 2 Active not recruiting

20 enrolled 11 charts

Genitourinary

Urinary Bladder Neoplasms

NCT03501381 2023-09-01

High Dose IL 2 and Entinostat in RCC

Phase 2 Active not recruiting

46 enrolled

Genitourinary

Carcinoma, Renal Cell

Clinical Trials

Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

High Dose IL 2 and Entinostat in RCC